HOME >> BIOLOGY >> NEWS
Dartmouth professor makes case for ethically universal stem cell lines

HANOVER, NH -- Human embryonic stem cells (hESC), those very young cells that are a biological blank slate, have the potential to become more specialized, contributing to the workings of a wide variety of organs and tissues. Their potential to treat diseases such as Parkinsons is slow to be realized because of the ongoing ethical debate over harvesting hESCs, a process called deriving hESC lines. Additionally, its a politically charged issue in the U.S. because it involves federal funding for research.

A recently published paper by Dartmouth Professor Ronald M. Green examines the moral questions and the scientific feasibility of deriving hESC lines in ways that avoid destroying living human embryos. The paper, published in the June 2007 issue of Nature Reviews Genetics, considers six current approaches: altered nuclear transfer, parthenogenesis, single-blastomere biopsy, somatic-cell dedifferentiation, the use of dead embryos, and the use of abnormal embryos. Greens goal, as stated in the paper, is to greatly accelerate hESC research that is closer to being universally acceptable.

I think we can pursue hESC research and also respect the sensitivities of our fellow citizens. Its not impossible to do both, says Green, the Eunice and Julian Cohen Professor for the Study of Ethics and Human Values, and the faculty director of the Dartmouth Ethics Institute. In addition to resolving current debates, he argues, these alternatives can make possible hESC lines that are ethically universal. These would be analogous to the universal O-type blood group: lines that could be used by anyone regardless of their ethical views on the moral status of the embryo.

Green, who is also an adjunct professor of community and family medicine at the Dartmouth Medical School, says, The six approaches differ in technique, most directly in how the blastocyst is created. The blastocyst, where hESCs are found, is the three- to five-day-old embryo that has not yet
'"/>

Contact: Sue Knapp
sue.knapp@dartmouth.edu
603-646-3661
Dartmouth College
7-Jun-2007


Page: 1 2

Related biology news :

1. Plants that produce more vitamin C may result from UCLA-Dartmouth discovery
2. Vitamin extends life in yeast, Dartmouth Medical School researchers find
3. Dartmouth researchers find that arsenic triggers unique mechanism in rare leukemia
4. Dartmouth researchers find that low doses of arsenic have broad impact on hormone activity
5. Dartmouth researchers identify a gene that enhances muscle performance
6. Dartmouth study contributes to research addressing malnutrition and iron deficiency
7. Genetic variation impacts aspirins effectiveness in preventing colon cancer, Dartmouth study finds
8. Dartmouth researchers find a neural signature of bilingualism
9. Dartmouth and GlycoFi report full humanization of therapeutic proteins from yeast
10. GlycoFi and Dartmouth report full humanization of yeast glycosylation pathway in Science
11. Dartmouth researchers find key player in immune system regulation

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted ... quarter of 2015 The gross margin was 49% (27) ... the operating margin was 40% (-13) Earnings per share ... operations was SEK 249.9 M (21.2) , Outlook   ... M. The operating margin for 2016 is estimated to ...
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... June 27, 2016 , ... Parallel 6 , the leading software as ... Clinical Reach Virtual Patient Encounter CONSULT module which enables both audio and video ... trial team. , Using the CONSULT module, patients and physicians can schedule a face ...
(Date:6/27/2016)... BOSTON , June 27, 2016   Ginkgo ... biology to industrial engineering, was today awarded as ... a selection of the world,s most innovative companies. ... at scale for the real world in the ... organism engineers work directly with customers including Fortune ...
(Date:6/24/2016)... ... ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical journal articles ... findings are the subject of a new article on the Surviving Mesothelioma website. ... blood, lung fluid or tissue of mesothelioma patients that can help point doctors to ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
Breaking Biology Technology:
Cached News: